Skip to main content

and
  1. No Access

    Article

    Therapy-induced APOBEC3A drives evolution of persistent cancer cells

    Acquired drug resistance to anticancer targeted therapies remains an unsolved clinical problem. Although many drivers of acquired drug resistance have been identified14, the underlying molecular mechanisms shapi...

    Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, Naveed Nikpour in Nature (2023)